GT Biopharma Inc (GTBP)
3.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
3.65
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Price: 3.65 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 3.65 | 3.65 | 3.65 | 3.65 | 0.000 |
| Apr 23, 2024 | 3.67 | 3.825 | 3.53 | 3.65 | 10589.00 |
| Apr 22, 2024 | 3.66 | 3.78 | 3.65 | 3.78 | 3469.00 |
| Apr 19, 2024 | 3.80 | 3.80 | 3.65 | 3.69 | 5907.00 |
| Apr 18, 2024 | 3.831 | 3.875 | 3.800 | 3.800 | 1025.00 |
| Apr 17, 2024 | 3.81 | 4.182 | 3.80 | 3.97 | 5813.00 |
| Apr 16, 2024 | 3.665 | 3.85 | 3.61 | 3.70 | 9955.00 |
| Apr 15, 2024 | 3.82 | 3.960 | 3.80 | 3.80 | 8000.00 |
| Apr 12, 2024 | 4.07 | 4.25 | 3.80 | 3.90 | 4870.00 |
| Apr 11, 2024 | 4.00 | 4.128 | 3.88 | 4.00 | 3219.00 |
| Apr 10, 2024 | 4.01 | 4.091 | 4.00 | 4.00 | 4247.00 |
| Apr 09, 2024 | 4.20 | 4.38 | 4.13 | 4.15 | 22857.00 |
| Apr 08, 2024 | 4.45 | 4.49 | 4.02 | 4.08 | 13700.00 |
| Apr 05, 2024 | 4.59 | 4.68 | 4.150 | 4.150 | 3577.00 |
| Apr 04, 2024 | 4.71 | 4.77 | 4.120 | 4.362 | 11988.00 |
| Apr 03, 2024 | 4.27 | 4.68 | 4.27 | 4.65 | 4860.00 |
| Apr 02, 2024 | 4.35 | 4.58 | 4.20 | 4.20 | 3829.00 |
| Apr 01, 2024 | 4.58 | 4.58 | 4.12 | 4.31 | 11212.00 |
| Mar 28, 2024 | 4.54 | 4.81 | 4.43 | 4.43 | 10831.00 |
| Mar 27, 2024 | 4.40 | 4.475 | 4.32 | 4.37 | 3878.00 |
| Mar 26, 2024 | 4.35 | 4.60 | 4.25 | 4.40 | 7704.00 |
| Mar 25, 2024 | 4.65 | 4.65 | 4.351 | 4.41 | 14179.00 |
| Mar 22, 2024 | 4.62 | 5.21 | 4.44 | 4.59 | 138771.0 |
| Mar 21, 2024 | 4.169 | 4.437 | 3.81 | 3.81 | 10086.00 |
| Mar 20, 2024 | 4.21 | 4.244 | 4.16 | 4.21 | 4262.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.65
Minimum
Apr 23 2024
568.80
Maximum
Jun 02 2021
103.23
Average
81.60
Median
Sep 12 2019
Price Benchmarks
| Cutera Inc | 1.96 |
| Outlook Therapeutics Inc | 8.20 |
| 180 Life Sciences Corp | 1.82 |
| Journey Medical Corp | 3.40 |
| NovaBay Pharmaceuticals Inc | 0.0773 |
Price Related Metrics
| PS Ratio | 78.86 |
| Price to Book Value | 0.6741 |
| Earnings Yield | -153.0% |
| Market Cap | 5.039M |